Yes. Dupixent is still prescribed for eczema, asthma, and sinus conditions. Investigations are ongoing to determine if patients are being fully informed about all potential risks.
FAQs Category: Dupixent Skin Cancer
No. Claims are being reviewed specifically for individuals who used Dupixent and were later diagnosed with CTCL, without prior diagnoses of other cancers such as Hodgkin or non-Hodgkin lymphoma.
A Dupixent attorney can review your situation, help you understand your options, and guide you through the next steps if you may qualify for a claim.
Nothing. Ward Black Law offers a free case review to help you determine whether you may be eligible.